Gary Littlejohn

Gary Littlejohn currently works at Atlantic Horizon Capital Corp., as Independent Non-Executive Director from 2025 and Midland Walwyn, Inc., as Senior Vice President.
Mr. Littlejohn also formerly worked at Helix BioPharma Corp., as Chief Executive Officer & Director from 2015 to 2016, Theratechnologies, Inc., as Independent Director from 2018 to 2023, Montréal Exchange, Inc., as Director from 1998 to 2000, Desjardins Securities, Inc., as Managing Director-Investment Banking, Aegera Therapeutics, Inc., as Director from 2008 to 2009, Arab National Investment Co., as Director & Member, Aegera Pharmaceuticals, as Director, Merrill Lynch & Co., Inc., as Principal, Teleglobe, Inc., as Principal, Bombardier, Inc., as Principal, Ecopia BioSciences, Inc., as Chief Financial Officer from 2000 to 2006, TD Securities, Inc., as Principal, Bce, as Principal, Equity Bank (Andover, Kansas), as Principal, and Arab National Bank Investment Co., as Advisor from 2014 to 2015.
Mr. Littlejohn received his undergraduate degree in 1979 and Masters Business Admin degree in 1982 from McGill University.